Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Holding(s) in Company

29th Jan 2009 17:33

RNS Number : 4954M
Lombard Medical Technologies PLC
29 January 2009
 



For filings with the FSA include the annex

For filings with issuer exclude the annex 

TR-1: Notifications of Major Interests in Shares

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

Lombard Medical Technologies plc

2. Reason for notification (yes/no)

An acquisition or disposal of voting rights

An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached 

An event changing the breakdown of voting rights

Other (please specify): CHANGE TO THE NUMBER OF VOTING RIGHTS IN ISSUE

X

3. Full name of person(s) subject to notification obligation:

Aviva plc & its subsidiaries

4. Full name of shareholder(s) (if different from 3):

Registered Holder:

 

BNY Norwich Union Nominees

Limited 999,049*

 

Chase GA Group Nominees Limited 3,018,538*

 

Chase Nominees Limited 258,000*

 

CUIM Nominee Limited 604,223*

 

Vidacos Nominees Limited 13,060*

 

 

* denotes direct interest

5. Date of transaction (and date on which the threshold is crossed or reached if different):

28 January 2009

6. Date on which issuer notified:

29 January 2009

7. Threshold(s) that is/are crossed or reached:

3% to

8: Notified Details

A: Voting rights attached to shares

Class/type of shares

If possible use ISIN code

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of shares

Number of voting rights

Number of shares Direct

Number of voting rights

Percentage of voting rights

Direct

Indirect

Direct

Indirect

Ordinary Shares

 

GB00B0Q5QP56

 

4,906,635

4,906,635

4,892,870

4,892,870

Not Disclosable

0.68%

Not Disclosable

B: Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date

Exercise/ conversion period/date 

No. of voting rights that may be acquired (if the instrument exercised/converted)

Percentage of voting rights

N/A

N/A

N/A

N/A

N/A

Total (A+B)

Number of voting rights

Percentage of voting rights

4,892,870

0.68%

9. Chain of controlled undertakings through which the voting rights and /or the financial instruments are effectively held, if applicable:

The voting rights are managed and controlled by A viva Investors Global Services Limited, with the following chain of controlled undertakings:-

Aviva Investors Global Services Limited;
Aviva plc (Parent Company)
Aviva Group Holdings Limited (wholly owned subsidiary of Aviva plc)
Aviva Investors Holdings Limited (wholly owned subsidiary of Aviva Group Holdings Limited)
Aviva Investors Global Services Limited (wholly owned subsidiary of Aviva Investors Holdings Limited)

 

Proxy Voting:

10. Name of proxy holder:

See Section 4

11. Number of voting rights proxy holder will cease to hold:

12. Date on which proxy holder will cease to hold voting rights:

13. Additional information:

Figures are based on a revised total number of voting rights of 721,420,846

14 Contact name:

Neil Whittaker

15. Contact telephone number:

01603 684420

For notes on how to complete form TR-1 please see the FSA website. 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUKABRKARAUAR

Related Shares:

Aviva
FTSE 100 Latest
Value8,554.80
Change23.19